Management of Aneurysmal Dilation of Main Pulmonary Artery
The management of pulmonary artery aneurysms should include surgical intervention when the main pulmonary artery is ≥3.0 cm in diameter or when symptoms or compression of adjacent structures occur, with referral to specialized centers with expertise in pulmonary vascular disease. 1
Diagnostic Criteria and Evaluation
A pulmonary artery aneurysm is defined as:
- Localized dilation of the pulmonary artery >1.5 times the upper normal limit
- Main pulmonary artery measuring ≥3.0 cm in diameter 2, 1
- Alternatively, when the pulmonary artery diameter equals or exceeds the ascending aorta diameter 2
Initial Assessment
Imaging studies:
- Echocardiography to assess right ventricular function and estimate pulmonary pressures 1
- CT scan to accurately measure pulmonary artery dimensions and relationship to surrounding structures
- MRI for detailed assessment of pulmonary vasculature and cardiac function
Hemodynamic evaluation:
- Right heart catheterization is mandatory to:
- Confirm pulmonary hypertension (if present)
- Measure mean pulmonary artery pressure (mPAP)
- Assess pulmonary vascular resistance 1
- Right heart catheterization is mandatory to:
Underlying cause investigation:
- V/Q scan to rule out chronic thromboembolic pulmonary hypertension (CTEPH) 1
- Assessment for congenital heart disease
- Evaluation for connective tissue disorders
- Screening for vasculitis
Management Algorithm
1. Asymptomatic Pulmonary Artery Aneurysm
For patients with asymptomatic pulmonary artery aneurysm:
Observation with regular monitoring if:
- Aneurysm <3.0 cm
- No evidence of pulmonary hypertension
- No compression of adjacent structures
- No rapid growth
Surgical intervention should be considered if:
- Aneurysm ≥3.0 cm
- Evidence of rapid growth (>0.5 cm/year)
- Development of symptoms
- Compression of adjacent structures 1
2. Symptomatic Pulmonary Artery Aneurysm
For patients with symptomatic pulmonary artery aneurysm:
- Urgent surgical intervention is recommended, which may include:
- Reduction pulmonary arterioplasty
- Main pulmonary artery replacement 1
3. Management Based on Underlying Cause
Pulmonary Hypertension
If pulmonary hypertension is the underlying cause:
- Initiate PAH-specific therapy based on classification:
- Endothelin receptor antagonists (bosentan, macitentan, ambrisentan)
- Phosphodiesterase-5 inhibitors
- Prostacyclins 1
Congenital Heart Disease
For aneurysms associated with congenital heart defects:
- Surgical correction of the underlying defect
- Consider combined repair of the aneurysm during the same procedure
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
For aneurysms associated with CTEPH:
- Pulmonary endarterectomy for operable cases
- Balloon pulmonary angioplasty for inoperable cases
- Riociguat for inoperable CTEPH
- Lifelong anticoagulation 1
Surgical Approaches
Reduction pulmonary arterioplasty:
- Indicated when the aneurysm is causing symptoms
- Appropriate when compressing contiguous structures
- Recommended when associated with pulmonary regurgitation and subsequent right ventricle enlargement 1
Main pulmonary artery replacement:
- Using prosthetic grafts (e.g., polytetrafluoroethylene vascular graft) 3
- Indicated for large aneurysms or when reduction arterioplasty is not feasible
Endovascular approaches:
- Stent implantation for significant proximal or distal branch pulmonary artery stenosis
- Pulmonary angioplasty for significant peripheral branch pulmonary artery stenosis 1
Follow-up and Monitoring
For patients with pulmonary artery aneurysms:
Regular echocardiography every 3-6 months to assess:
- Right ventricular function
- Pulmonary artery dimensions
- Pulmonary pressures 1
Functional assessment with 6-minute walk test every 3-6 months 1
BNP/NT-proBNP monitoring to assess for right heart failure 1
Repeat imaging (CT or MRI) annually or more frequently if:
- Aneurysm is borderline for intervention
- Growth rate is concerning
- New symptoms develop
Important Considerations and Pitfalls
Referral to specialized centers: Patients with pulmonary artery aneurysms should be referred to centers with expertise in pulmonary vascular disease 1
Risk of rupture: Unlike aortic aneurysms, the relationship between pulmonary artery aneurysm size and rupture risk is not well defined 4
Diagnostic challenges: Pulmonary artery aneurysms often present with non-specific symptoms (cough, dyspnea) or may be asymptomatic, leading to delayed diagnosis 4, 5
Rare complication: Chest pain may occur due to compression of the left main coronary artery by markedly enlarged pulmonary artery aneurysms 2
Individualized approach: Management decisions should consider the patient's age, comorbidities, and surgical risk, though these factors are not absolute contraindications to intervention 1